Drug Shortage Report for HEPARIN LEO INJ 1000UNIT/ML
| Report ID | 176999 |
| Drug Identification Number | 00453811 |
| Brand name | HEPARIN LEO INJ 1000UNIT/ML |
| Common or Proper name | Sodium Heparin injection |
| Company Name | LEO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPARIN SODIUM |
| Strength(s) | 1000UNIT |
| Dosage form(s) | LIQUID |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 10 x 10 mL vial |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-12-02 |
| Actual start date | |
| Estimated end date | 2022-12-12 |
| Actual end date | 2022-12-12 |
| Shortage status | Resolved |
| Updated date | 2022-12-13 |
| Company comments | Increase in demand due to competitor out of stock |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3389 STEELES AVENUE EAST, SUITE 110 TORONTO, ONTARIO CANADA M2H 3S8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-12-13 | English | Compare |
| v5 | 2022-12-12 | French | Compare |
| v4 | 2022-12-12 | English | Compare |
| v3 | 2022-12-03 | English | Compare |
| v2 | 2022-12-02 | French | Compare |
| v1 | 2022-12-02 | English | Compare |
Showing 1 to 6 of 6